DeNovX LLC is an innovative technology company based in Chicago and San Diego that specializes in improving efficiencies in pharmaceutical development, structure-based drug design, and continuous flow manufacturing. Their surface science approaches and slot-in products enhance the formation of crystalline solids, reducing challenges in generating crystalline active pharmaceutical ingredients (APIs) and saving significant time in API solid form development.
With a portfolio of 22 issued patents, DeNovX has established broad intellectual property rights in major pharmaceutical markets worldwide. Their technologies have shown remarkable results, including 50% reductions in crystallization onset times for APIs and a 3-fold increase in protein crystallization hits, leading to advancements in structural biology and structure-based drug design. Additionally, DeNovX is developing a patented continuous flow manufacturing antisolvent crystallization approach that could potentially reduce pharmaceutical production costs by up to 50%.
Generated from the website
